Literature DB >> 27889705

Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.

Menglan Pang, Tibor Schuster, Kristian B Filion, Mireille E Schnitzer, Maria Eberg, Robert W Platt.   

Abstract

Inverse probability of treatment weighting (IPW) and targeted maximum likelihood estimation (TMLE) are relatively new methods proposed for estimating marginal causal effects. TMLE is doubly robust, yielding consistent estimators even under misspecification of either the treatment or the outcome model. While IPW methods are known to be sensitive to near violations of the practical positivity assumption (e. g., in the case of data sparsity), the consequences of this violation in the TMLE framework for binary outcomes have been less widely investigated. As near practical positivity violations are particularly likely in high-dimensional covariate settings, a better understanding of the performance of TMLE is of particular interest for pharmcoepidemiological studies using large databases. Using plasmode and Monte-Carlo simulation studies, we evaluated the performance of TMLE compared to that of IPW estimators based on a point-exposure cohort study of the marginal causal effect of post-myocardial infarction statin use on the 1-year risk of all-cause mortality from the Clinical Practice Research Datalink. A variety of treatment model specifications were considered, inducing different degrees of near practical non-positivity. Our simulation study showed that the performance of the TMLE and IPW estimators were comparable when the dimension of the fitted treatment model was small to moderate; however, they differed when a large number of covariates was considered. When a rich outcome model was included in the TMLE, estimators were unbiased. In some cases, we found irregular bias and large standard errors with both methods even with a correctly specified high-dimensional treatment model. The IPW estimator showed a slightly better root MSE with high-dimensional treatment model specifications in our simulation setting. In conclusion, for estimation of the marginal expectation of the outcome under a fixed treatment, TMLE and IPW estimators employing the same treatment model specification may perform differently due to differential sensitivity to practical positivity violations; however, TMLE, being doubly robust, shows improved performance with richer specifications of the outcome model. Although TMLE is appealing for its double robustness property, such violations in a high-dimensional covariate setting are problematic for both methods.

Entities:  

Mesh:

Year:  2016        PMID: 27889705      PMCID: PMC5777857          DOI: 10.1515/ijb-2015-0034

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  35 in total

1.  Collaborative double robust targeted maximum likelihood estimation.

Authors:  Mark J van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2010-05-17       Impact factor: 0.968

2.  A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use.

Authors:  Peter C Austin; Muhammad M Mamdani
Journal:  Stat Med       Date:  2006-06-30       Impact factor: 2.373

3.  Super learning: an application to the prediction of HIV-1 drug resistance.

Authors:  Sandra E Sinisi; Eric C Polley; Maya L Petersen; Soo-Yon Rhee; Mark J van der Laan
Journal:  Stat Appl Genet Mol Biol       Date:  2007-02-23

4.  Studying noncollapsibility of the odds ratio with marginal structural and logistic regression models.

Authors:  Menglan Pang; Jay S Kaufman; Robert W Platt
Journal:  Stat Methods Med Res       Date:  2013-10-09       Impact factor: 3.021

5.  A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome.

Authors:  Susan Gruber; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010-08-01       Impact factor: 0.968

6.  Implementation of G-computation on a simulated data set: demonstration of a causal inference technique.

Authors:  Jonathan M Snowden; Sherri Rose; Kathleen M Mortimer
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

7.  A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis.

Authors:  Ori M Stitelman; Victor De Gruttola; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-09-18       Impact factor: 0.968

8.  EFFECT OF BREASTFEEDING ON GASTROINTESTINAL INFECTION IN INFANTS: A TARGETED MAXIMUM LIKELIHOOD APPROACH FOR CLUSTERED LONGITUDINAL DATA.

Authors:  Mireille E Schnitzer; Mark J van der Laan; Erica E M Moodie; Robert W Platt
Journal:  Ann Appl Stat       Date:  2014-06       Impact factor: 2.083

9.  Variable Selection for Confounder Control, Flexible Modeling and Collaborative Targeted Minimum Loss-Based Estimation in Causal Inference.

Authors:  Mireille E Schnitzer; Judith J Lok; Susan Gruber
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

10.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

View more
  3 in total

1.  Visualization tool of variable selection in bias-variance tradeoff for inverse probability weights.

Authors:  Ya-Hui Yu; Kristian B Filion; Lisa M Bodnar; Maria M Brooks; Robert W Platt; Katherine P Himes; Ashley I Naimi
Journal:  Ann Epidemiol       Date:  2019-12-13       Impact factor: 3.797

2.  Estimating long-term treatment effects in observational data: A comparison of the performance of different methods under real-world uncertainty.

Authors:  Simon J Newsome; Ruth H Keogh; Rhian M Daniel
Journal:  Stat Med       Date:  2018-04-19       Impact factor: 2.373

3.  Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies.

Authors:  Ingrid S Sketris; Nancy Carter; Robyn L Traynor; Dorian Watts; Kim Kelly
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-20       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.